Cargando…
Pregnancy and COVID‐19: pharmacologic considerations
In this review, we summarize evidence regarding the use of routine and investigational pharmacologic interventions for pregnant and lactating patients with coronavirus disease 2019 (COVID‐19). Antenatal corticosteroids may be used routinely for fetal lung maturation between 24 and 34 weeks' ges...
Autores principales: | D'Souza, R., Ashraf, R., Rowe, H., Zipursky, J., Clarfield, L., Maxwell, C., Arzola, C., Lapinsky, S., Paquette, K., Murthy, S., Cheng, M. P., Malhamé, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537532/ https://www.ncbi.nlm.nih.gov/pubmed/32959455 http://dx.doi.org/10.1002/uog.23116 |
Ejemplares similares
-
Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections
por: Briller, Joan E., et al.
Publicado: (2022) -
The pharmacological management of depression
por: Kupfer, David J.
Publicado: (2005) -
Pharmacological approaches to the challenge of treatment-resistant depression
por: Ionescu, Dawn F., et al.
Publicado: (2015) -
The intersection of pharmacology, imaging, and genetics in the development of personalized medicine
por: Gerretsen, Philip, et al.
Publicado: (2009) -
The ethics of forgoing life-sustaining treatment: theoretical considerations and clinical decision making
por: Welie, Jos VM, et al.
Publicado: (2014)